Molecular Partners (MOLN) Projected to Post Quarterly Earnings on Thursday

Molecular Partners (NASDAQ:MOLN) is expected to announce its earnings results before the market opens on Thursday, March 6th. Analysts expect the company to announce earnings of ($0.45) per share for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link.

Molecular Partners Trading Down 7.0 %

NASDAQ MOLN opened at $4.68 on Tuesday. Molecular Partners has a 1-year low of $3.32 and a 1-year high of $12.70. The company has a market capitalization of $188.90 million, a PE ratio of -2.18 and a beta of 1.06. The firm’s fifty day simple moving average is $5.14 and its 200-day simple moving average is $5.41.

About Molecular Partners

Molecular Partners AG, a clinical-stage biotechnology company, develops designed ankyrin repeat proteins therapeutics for the treatment of oncology and virology diseases in Switzerland. The company develops MP0317, a CD40 agonist designed to activate immune cells within the tumor microenvironment by anchoring to fibroblast activation protein that is in Phase I clinical trial; and MP0533, a novel tetra-specific T cell-engaging DARPin for acute myeloid leukemia.